Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (441-450 of 666) with videos related to

Pageof 67
Sort By:
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
BJU International|June 6, 2017
Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution studyVasu Tumati, William C Jackson, Ahmed E Abugharib, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2012
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgeryBrett W Cox, Daniel E Spratt, Michael Lovelock, et al.
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Pageof 67

Showing results (441-450 of 666) with videos related to

Sort By:
Pageof 67
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
BJU International|June 6, 2017
Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution studyVasu Tumati, William C Jackson, Ahmed E Abugharib, et al.
European Urology|July 19, 2017
A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate CancerDaniel E Spratt, Robert T Dess, Zachary S Zumsteg, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2012
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgeryBrett W Cox, Daniel E Spratt, Michael Lovelock, et al.
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
European Urology|March 9, 2023
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 TrialSoumyajit Roy, Yilun Sun, Scott C Morgan, et al.
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
JNCI Cancer Spectrum|October 5, 2023
Individual-level home values and cancer mortality in a statewide registryAlec Zhu, Stephen Rhodes, Weichuan Dong, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Pageof 67